Actuarial Analysis
Antineoplastic Combined Chemotherapy Protocols/adverse effects/*therapeutic use
Child
Clinical Trials as Topic/*statistics & numerical data
Confidence Intervals
Follow-Up Studies
Humans
Lymphoma, B-Cell/*drug therapy/mortality
Proportional Hazards Models
Survival Analysis
Survival Rate
